Recruiting Scleroderma Studies in Worcester
About Scleroderma Clinical Trials in Worcester
Scleroderma is an autoimmune connective tissue disease characterized by hardening and tightening of the skin and connective tissues. Systemic sclerosis can also affect internal organs including lungs, kidneys, and heart. Treatment is directed at specific symptoms and organ involvement.
There are currently 1 scleroderma clinical trials recruiting participants in Worcester, MA. These studies are seeking a combined 92 participants. Research is being sponsored by Juno Therapeutics, Inc., a Bristol-Myers Squibb Company. Clinical trial participation is free and participants receive study-related medical care at no cost.
Scleroderma Clinical Trials in Worcester — FAQ
Are there scleroderma clinical trials in Worcester?
Yes, there are 1 scleroderma clinical trials currently recruiting in Worcester, MA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Worcester?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Worcester research site will contact you about next steps.
Are clinical trials in Worcester free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Worcester studies also compensate for your time and travel.
What scleroderma treatments are being tested?
The 1 active trials in Worcester are testing new therapies including novel drugs, biologics, and treatment approaches for scleroderma.
Data updated July 22, 2026 from ClinicalTrials.gov